Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05621460

The Effect of Water Carbonation on Orthostatic Tolerance

The primary purpose of this investigation is to determine whether water carbonation can improve orthostatic tolerance in healthy control volunteers. Orthostatic tolerance refers to the ability to maintain an adequate blood pressure when standing. In some individuals blood pressure can fall when standing, predisposing to dizzy spells or fainting episodes. Drinking water can boost blood pressure and making fainting episodes less likely. However, it is not clear whether the carbonation of the water has any further impact on the blood pressure response. This is important because it may be that carbonated water expands the stomach (gastric distension), provoking an increase in sympathetic activity. The increase in sympathetic nervous system activity boosts blood pressure. Resolving this question would have important implications for patients with syncope. This study will test whether carbonated water will have any further impact on blood pressure than the already known effect of non-carbonated water.

Recruiting

Interested in participating?

Request Info

Key information

Age range

19 year–50 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Simon Fraser University

Burnaby, British Columbia, V5A 1S6, Canada

Location status: Recruiting

Location contact

Vera-Ellen M Lucci, PhD

CONTACT

[email protected]

7787828560

Vera-Ellen M Lucci, PhD

SUB_INVESTIGATOR

Victoria E Claydon, PhD

PRINCIPAL_INVESTIGATOR

About this study

The primary purpose of this investigation is to determine whether water carbonation can improve orthostatic tolerance in healthy control volunteers. Orthostatic tolerance refers to the ability to maintain an adequate blood pressure when standing [1]. In some individuals blood pressure can fall when standing, predisposing to dizzy spells or fainting episodes [1]. Drinking water can boost blood pressure and making fainting episodes less likely [2-8]. However, it is not clear whether the carbonation of the water has any further impact on the blood pressure response [9,10]. This is important because it may be that carbonated water expands the stomach (gastric distension), provoking an increase in sympathetic activity. The increase in sympathetic nervous system activity boosts blood pressure. Resolving this question would have important implications for patients with syncope. This study will test whether carbonated water will have any further impact on blood pressure than the already known effect of non-carbonated water.

Volunteers (n=25) will be asked to undergo a "tilt test" to assess cardiovascular reflex control and orthostatic tolerance (measured as time to presyncope, or near fainting, in minutes). It has been previously shown that this technique to be reproducible, reliable, and to have high sensitivity and specificity for differentiating persons with differing orthostatic tolerance, or for examining the effects of interventions aimed at improving orthostatic tolerance [4,6,11-18].

Volunteers will undergo this test on three separate days. On each day participants will be asked to drink a glass of water: either a 50ml drink of room temperature water (control condition), a 500ml drink of flat (non-carbonated) room temperature water, or a 500ml drink of carbonated room temperature water. The study will be conducted in a randomised, single-blind fashion. The investigator responsible for terminating the test will be blinded as to the water condition on each test day, rendering the study single blind. It will not be possible to blind participants as to the carbonation of the water, however, participants will not be informed as to the hypothesised impact of the water conditions.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • healthy, English-speaking

Exclusion criteria

  • pregnancy or suspected pregnancy, history of cardiovascular disease, history of neurological disease, history of recurrent fainting (≥ 2 episodes of fainting with loss of consciousness in the prior 6 months)

Treatment and study plan

500mL carbonated water

Other

Drink 500mL carbonated water immediately prior to head-up tilt test

500mL still water

Other

Drink 500mL still water immediately prior to head-up tilt test

50mL still water

Other

Drink 50mL still water immediately prior to head-up tilt test

Primary outcomes

  1. Orthostatic tolerance

    Time frame: 0-50 minutes

    The time, in minutes, to presyncope (near-fainting) after the initiation of head-up tilt

Study contacts

Contact information is provided by the study sponsor or research team.

Vera-Ellen M Lucci, PhD

CONTACT

[email protected]

7787828560

Victoria E Claydon, PhD

CONTACT

[email protected]

7787828513

Sponsors and collaborators

Lead sponsor

Simon Fraser University

Other

Registry information

Important dates

Study start
2023
Primary completion
2027
Study completion
2027
First posted
Nov 18, 2022
Registry last updated
Apr 23, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.